Cystatin C modulates cerebral β-amyloidosis

Nature Genetics

Volumn 39, Issue 12, 2007, Pages 1437-1439

  Kaeser, Stephan A ^a   Herzig, Martin C ^a   Coomaraswamy, Janaky ^a   Kilger, Ellen ^a   Selenica, Maj Linda ^b   Winkler, David T ^c   Staufenbiel, Matthias ^d   Levy, Efrat ^e,f   Grubb, Anders ^b   Jucker, Mathias ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF BASEL   (Switzerland)

^d NOVARTIS PHARMA AG   (Switzerland)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CYSTATIN C;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CEREBRAL BETA AMYLOIDOSIS; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; GENETIC RISK; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RISK ASSESSMENT;

MUS MUSCULUS;

EID: 36549085086     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2007.23     Document Type: Article

References (15)

1. Levy, E. et al. Brain Pathol. 16, 60-70 (2006).
2. Herzig, M.C. et al. Nat. Neurosci. 7, 954-960 (2004).
3. Radde, R. et al. EMBO Rep. 7, 940-946 (2006).
4. Selenica, M.L. et al. Scand. J. Clin. Lab. Invest. 67, 179-190 (2007).
5. Balbin, M. et al. Biol. Chem. Hoppe Seyler 373, 471-476 (1992).
6. Finckh, U. et al. Arch. Neurol. 57, 1579-1583 (2000).
7. Cathcart, H.M. et al. Neurology 64, 755-757 (2005).
8. Bertram, L. et al. Nat. Genet. 39, 17-23 (2007).
9. Benussi, L. et al. Neurobiol. Dis. 13, 15-21 (2003).
10. Paraoan, L. et al. Traffic 5, 884-895 (2004).
11. Eriksson, P. et al. Arterioscler. Thromb. Vasc. Biol. 24, 551-557 (2004).
12. Chuo, L.J. et al. Dement. Geriatr. Cogn. Disord. 23, 251-257 (2007).
13. Ghidoni, R. et al. Neurobiol. Aging 28, 371-376 (2007).
14. Bjarnadottir, M. et al. Amyloid 8, 1-10 (2001).
15. Filler, G. et al. Clin. Biochem. 38, 1-8 (2005).